Your browser doesn't support javascript.
loading
Pharmacokinetics after a single dose of naloxone administered as a nasal spray in healthy volunteers.
Vanky, E; Hellmundt, L; Bondesson, U; Eksborg, S; Lundeberg, S.
Affiliation
  • Vanky E; Department of Anesthesia and Intensive Care, Visby Hospital, Visby, Sweden.
  • Hellmundt L; Department of Pediatric Anesthesia and Intensive Care, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
  • Bondesson U; Department of Chemistry, Environment and Feed Hygiene, National Veterinary Institute (SVA), Uppsala, Sweden.
  • Eksborg S; Childhood Cancer Research Unit, Department of Woman and Child Health, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden.
  • Lundeberg S; Department of Anesthesia and Intensive Care, Visby Hospital, Visby, Sweden.
Acta Anaesthesiol Scand ; 61(6): 636-640, 2017 Jul.
Article in En | MEDLINE | ID: mdl-28444856

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Naloxone / Narcotic Antagonists Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Acta Anaesthesiol Scand Year: 2017 Type: Article Affiliation country: Sweden

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Naloxone / Narcotic Antagonists Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Acta Anaesthesiol Scand Year: 2017 Type: Article Affiliation country: Sweden